TLR7 and infection: Collectively, these findings indicate that the latency reversing effect of TLR7 agonists in NHPs might be very sensitive to alterations in model conditions such as timing of treatment initiation in relation to the course of infection, immune status, and SIV/SHIV challenge strain.